Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Intimate Rose vs PrescribedRX

Intimate Rose
Graded #137

Higher grade

vs+10.299999999999997
PrescribedRX
Graded #360

Lower grade

The verdict

Intimate Rose takes it — 69.1/100 to 58.8/100.

Intimate Rose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIntimate Rose +19
65
46
Dose & formulationIntimate Rose +19
96
77
Clinical oversightIntimate Rose +2
76
74
Labs & monitoringEven
52
52
FulfillmentEven
64
64
Contract termsIntimate Rose +17
37
20
Intimate Rose · left barPrescribedRX · right bar

The numbers

MetricIntimate RosePrescribedRX
WeighScore69.1/10058.8/100
GradeCC
Scorecard rank#137#360
Semaglutide$169/mo (all doses, compounded)$189/mo (compounded)
Tirzepatide$169/mo (all doses, compounded)$276/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Intimate Rose

Graded #137 · C

Strengths

  • Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
  • Medication and free delivery included, HSA and FSA eligible, no contract
  • Backed by an established women's-health brand using the OpenLoop provider network

Where it loses points

  • State availability not published
  • Oral compounded GLP-1 only; no injectable option shown
  • No specific compounding pharmacy named (network fulfillment via OpenLoop)
PrescribedRX

Graded #360 · C

Strengths

  • Compounded semaglutide ($189/mo) and tirzepatide ($276/mo) injectables, with lower per-month pricing on the 3-month plans ($176 and $233/mo)
  • Clear, upfront plan pages showing monthly and multi-month pricing with no surprise fees
  • Care from licensed US providers with monthly home delivery and ongoing dose support
  • Bilingual English/Spanish site and a broader telehealth menu (TRT, longevity, hair, sexual health) for people who want more than weight loss

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the intake
  • Compounding pharmacies aren't named on the site
  • Mid-range pricing — cheaper compounded GLP-1 options exist and the 3-month discount is modest
  • Compounded semaglutide and tirzepatide injectables only — no brand-name or oral options
  • Self-hosted affiliate program (not a vetted network); Florida/Palm Beach framing suggests a regional lean

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard